Oscar Health Inc. (OSCR) News
Filter OSCR News Items
OSCR News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
OSCR News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest OSCR News From Around the Web
Below are the latest news stories about OSCAR HEALTH INC that investors may wish to consider to help them evaluate OSCR as an investment opportunity.
Why Oscar Health (OSCR) Stock Crashed on FridayWe recently published a list of 10 Stocks that Crashed on Friday. In this article, we are going to take a look at where Oscar Health (NYSE:OSCR) stands against other companies mirroring Wall Street’s downturn. Wall Street’s main indices finished the shortened trading week in the negative territory, dampened by labor market data that came […] |
What Makes Oscar Health (OSCR) a Potential Bet?ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. A partial change in leadership in the second half of 2024 may continue into 2025 as a number of macro factors stabilize and small-cap earnings growth is expected […] |
Oscar Health, Inc. 2024 Fourth Quarter and Full Year Earnings Conference CallNEW YORK, January 09, 2025--Oscar Health, Inc. ("Oscar" or the "Company") (NYSE: OSCR), a leading healthcare technology company, will release its fourth quarter and full year 2024 financial results after the market closes on Tuesday, February 4, 2025. |
Oscar Health Inc (NYSE:OSCR): A Bullish Investment PerspectiveWe came across a long thesis on Oscar Health Inc (NYSE:OSCR) on ValueInvestorsClub by miser861. In this article we will summarize the bulls’ thesis on OSCR. The company’s shares were trading at $18.28 when this thesis was published, vs. closing price of $14.35 on Jan 3rd. Oscar Health Inc (NYSE:OSCR) is the first health insurance […] |
Here's Why Oscar Health, Inc. (OSCR) Fell More Than Broader MarketIn the most recent trading session, Oscar Health, Inc. (OSCR) closed at $13.44, indicating a -1.03% shift from the previous trading day. |
Oscar Health, Inc. (OSCR) Registers a Bigger Fall Than the Market: Important Facts to NoteThe latest trading day saw Oscar Health, Inc. (OSCR) settling at $13.58, representing a -1.59% change from its previous close. |
Novo Nordisk is 'losing its pep' in GLP-1 race: BMO analystComing off of Novo Nordisk's (NVO) sharp stock decline after its experimental weight-loss shot CagriSema was found to help recipients lose less weight than previously forecasted, BMO Capital Markets cut its price target on the pharmaceutical company from $156 to $105 per share. "This was supposed to be Novo's answer to Tirzepatide and Retatrutide, some higher efficacy drugs, and it kind of feels like where no man's land here. So we're really focused on next year when it comes to 4Q results, that's going to set the tone for the commercial side of these products for both Lilly and Novo," BMO Capital Markets managing director of biopharma equity research Evan Seigerman explains. "And then mid-year for Lilly, we have Orforglipron, which is their small molecule pill GLP-1, which could really... |
3 biggest catalysts expected for healthcare in 2025After an eventful year in the pharmaceutical and biotech industries, what lies ahead for the health landscape in 2025? Yahoo Finance senior health reporter Anjalee Khemlani outlines the three biggest catalysts for change and innovation for healthcare in the new year, including GLP-1 weight-loss drugs and proposed regulations on pharmacy benefit managers (PBMs) from the second Trump administration. To watch more expert insights and analysis on the latest market action, check out more Catalysts here. This post was written by Luke Carberry Mogan. |
The healthcare 'barriers' that made this fmr. insurance exec. walk awayIt has been nearly three weeks since UnitedHealthcare (UNH) CEO Brian Thompson was shot and killed in New York City. The suspected gunman, Luigi Mangione, has been charged with several counts of murder and even terrorism, which he pleaded not guilty to on Monday. In the aftermath of this event, Americans have expressed an outcry over their frustrations with dealing with health insurance providers and maneuvering the cracks in the US healthcare system. Center for Health and Democracy (CHD) President Wendell Potter joins Market Domination's Josh Lipton and Yahoo Finance senior health reporter Anjalee Khemlani to speak more about his self-described "crisis of conscience" when he worked within the health industry. Potter penned a New York Times op-ed piece last week titled I Was a Health In... |
Oscar Health, Inc. (OSCR) Ascends While Market Falls: Some Facts to NoteThe latest trading day saw Oscar Health, Inc. (OSCR) settling at $13.50, representing a +0.9% change from its previous close. |